Cubist Pharmaceuticals, Inc.

Despite being the poster child for pharmaceutical companies addressing the pandemic, Pfizer Inc. * saw its stock price lag the NYSE Arca Pharmaceutical Index (DRG) for the first part of 2021 until it

A fixed-combination product that contains a new active moiety and an antibiotic approved prior to 1997 is eligible for five-year new chemical entity exclusivity, the US Food and Drug Administration sa

Although the acquisitions of Celgene Corporation and Alexion Pharmaceuticals Inc. by Bristol Myers Squibb Company (BMS) and AstraZeneca PLC , respectively, were not given the best reception by

Relay Therapeutics, Inc. had the third-largest biopharmaceutical initial public offering in the US in 2020 when it sold 20 million shares at $20 each to gross $400m. It was the first of four IPOs by